The secrets of the bone marrow niche: Metabolic priming for AML.
about
Targeted Therapies in Adult B-Cell MalignanciesChemical metabolic inhibitors for the treatment of blood-borne cancersCombination of bortezomib and mitotic inhibitors down-modulate Bcr-Abl and efficiently eliminates tyrosine-kinase inhibitor sensitive and resistant Bcr-Abl-positive leukemic cells.Bone marrow niche-mediated survival of leukemia stem cells in acute myeloid leukemia: Yin and Yang.Leukemia cells induce changes in human bone marrow stromal cells.
P2860
The secrets of the bone marrow niche: Metabolic priming for AML.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
The secrets of the bone marrow niche: Metabolic priming for AML.
@en
The secrets of the bone marrow niche: Metabolic priming for AML.
@nl
type
label
The secrets of the bone marrow niche: Metabolic priming for AML.
@en
The secrets of the bone marrow niche: Metabolic priming for AML.
@nl
prefLabel
The secrets of the bone marrow niche: Metabolic priming for AML.
@en
The secrets of the bone marrow niche: Metabolic priming for AML.
@nl
P2093
P2860
P356
P1433
P1476
The secrets of the bone marrow niche: Metabolic priming for AML.
@en
P2093
David T Scadden
Rushdia Z Yusuf
Ying-Hua Wang
P2860
P2888
P304
P356
10.1038/NM.2831
P407
P577
2012-06-06T00:00:00Z